医生组织与药房之间的自给药药物整合趋势
Pragya Kakani1, David M Cutler2,3, Meredith B Rosenthal4
1Department of Population Health Sciences, Weill Cornell Medical College, New York, New York.
JAMA network open
|February 19, 2024
概括
医生组织越来越多地使用内部药房购买高成本药物,提供更低的价格. 这一趋势,特别是在瘤学中,需要进一步研究患者护理的影响.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 制药经济学 制药经济学
- 卫生政策 卫生政策
背景情况:
- 医生组织和药房之间的整合是一个日益增长的趋势,影响医疗保健的质量和成本.
- 内部药房在医生组织中的作用仍然不太清楚.
- 了解这种整合对于评估医疗保健提供模式至关重要.
研究的目的:
- 分析医生组织使用内部药房的趋势.
- 确定运营内部药房的医生组织的特点.
- 检查与其他药店相比,公司内部药店的药品定价.
主要方法:
- 一项跨部门研究分析了从2011年到2019年的医疗保险D部分收费服务受益人.
- 评估处方填充,医疗保险D部分支出和药物价格.
- 对医生组织特征和五个专业的内部药房流行情况的分析.
主要成果:
- 医疗保险D部分对高成本药物的支出显著增长,这些药物在内部药房填充 (例如,口服抗癌药物从10%增加到34%).
- 到2019年,大量的瘤学,泌尿病学和传染病专家是拥有内部药房的组织的一部分.
- 较大的医生组织和参与340B药品折扣计划的医生组织更有可能拥有内部药房. 高成本药物的价格在公司内部药房下降了1.76%.
结论:
- 医生组织经营的内部药房在2011-2019年期间使用量增加,特别是高成本药物.
- 虽然内部药房为高成本药物提供了较低的价格,但它们的扩张需要了解对患者护理的更广泛影响.
- 对医生组织的财政激励可能会推动内部药房的增长.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Integrated Healthcare System
1.6K
An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
1.6K
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Drug Delivery: Miscellaneous Routes
339
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
339
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Administration and Therapy Phases: Overview
465
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
465


